October 2025
1. LIU M, Dhakal H, Li H, Murakami M, et al
   Prostaglandin D2 axis impairs immunity against melanoma via dendritic cells and gammadelta T cells in middle-aged mice.
   J Immunol. 2025 Oct 28:vkaf288. doi: 10.1093.
   

   >> Share

   
   
2. REN Y, Ballard DJ, Kumar A, Song AF, et al
   eEF2K promotes immune evasion in melanoma via Cyclin D1-mediated stabilization of PD-L1.
   J Immunol. 2025 Oct 16:vkaf278. doi: 10.1093.
   

   >> Share

   
   
3. REINARTZ DM, Escamilla-Rivera V, Shao M, Tribble SL, et al
   Impact of absent in melanoma 2 on head and neck squamous cell carcinoma development.
   J Immunol. 2025 Oct 3:vkaf224. doi: 10.1093.
   

   >> Share

   
   August 2025
4. TANEGASHIMA K, Esashi E, Ishida K, Kotaki A, et al
   CXCL14 is an essential modulator of TLR9 agonist-induced antitumor immune responses.
   J Immunol. 2025;214:2076-2086.
   

   >> Share

   
   September 2024
5. DIAMANTOPOULOS N, Li J, Bouchard A, Joumier L, et al
   ICOS-expressing Regulatory T Cells Influence the Composition of Antitumor CTL Populations.
   J Immunol. 2024;213:753-762.
   

   >> Share

   
   July 2024
6. ADAM K, Lipatova Z, Abdul Ghafoor Raja M, Mishra AK, et al
   Cutting Edge: LAG3 Dimerization Is Required for TCR/CD3 Interaction and Inhibition of Antitumor Immunity.
   J Immunol. 2024;213:7-13.
   

   >> Share

   
   December 2023
7. PEIL J, Vossen C, Bock F, Clahsen T, et al
   Combined Osteopontin Blockade and Type 2 Classical Dendritic Cell Vaccination as Effective Synergetic Therapy for Conjunctival Melanoma.
   J Immunol. 2023 Dec 15:ji2300063. doi: 10.4049/jimmunol.2300063.
   

   >> Share

   
   
8. SINGH S, Xiao Z, Bavisi K, Roszik J, et al
   Corrections: IL-1alpha mediates innate and acquired resistance to immunotherapy in melanoma.
   J Immunol. 2023 Dec 13:ji2300689. doi: 10.4049/jimmunol.2300689.
   

   >> Share

   
   July 2023
9. THOMPSON B, Strange A, Amato CM, Hester-McCullough J, et al
   CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy.
   J Immunol. 2023 Jul 19:ji2300250. doi: 10.4049/jimmunol.2300250.
   

   >> Share

   
   March 2023
10. ALAM MM, Gower T, Jiang M, Oppenheim JJ, et al
    A Therapeutic Vaccine in Combination with Cyclic GMP-AMP Cures More Differentiated Melanomas in Mice.
    J Immunol. 2023 Mar 22:ji2200371. doi: 10.4049/jimmunol.2200371.
    

    >> Share

    
    July 2021
11. CARLSON PM, Mohan M, Patel RB, Birstler J, et al
    Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.
    J Immunol. 2021;207:720-734.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share